The human papillomavirus 9-valent vaccine, recombinant, or 9vHPV, provides protection against how many HPV serotypes?

The 9-valent HPV vaccine, also known as 9vHPV, is specifically designed to provide protection against nine different serotypes of the human papillomavirus. These serotypes include the high-risk HPV types that are most commonly associated with the development of cervical cancer, as well as other cancers and genital warts. By targeting these nine types—6, 11, 16, 18, 31, 33, 45, 52, and 58—the vaccine offers a broader protection compared to earlier vaccines that covered fewer serotypes. This makes it a crucial tool in the prevention of HPV-related diseases, further emphasizing its importance in public health initiatives aimed at reducing the incidence of cervical cancer and other HPV-related conditions.